Intrinsic Value of S&P & Nasdaq Contact Us

Endexx Corporation EDXC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
29/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Endexx Corporation (EDXC) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 27/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
43/100
→ Income
GROWTH
90/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — EDXC

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.03
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-0.01 $126.26K $-1.17M -926.2%
2016 $0.00 $220.76K $-776.66K -351.8%
2017 $0.00 $418.39K $-668.73K -159.8%
2018 $-0.01 $797.55K $-1.74M -217.9%
2019 $-0.03 $1.5M $-11.39M -760.3%
2020 $-0.03 $1.97M $-11.19M -567.9%
2021 $-0.02 $650.52K $-7.76M -1192.7%
2022 $-0.01 $1.28M $-4.9M -383.2%
2023 $-0.01 $3.91M $-6.5M -166.3%
2024 $-0.01 $1.66M $-3.4M -205.2%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message